
|Videos|January 30, 2023
Updates on Selinexor Triplet Combination Therapies from ASH 2022
Author(s)Joshua Richter, MD, Srdan Verstovsek, MD, PhD
Joshua Richter, MD, highlights key data from an update to a study investigating a selinexor triplet combination therapy.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5









































